Cargando…
ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial
OBJECTIVE: Obstructive sleep apnoea (OSA), atrial fibrillation (AF) and sudden cardiac death (SCD) may occur concomitantly, and are of considerable epidemiological interest, potentially leading to morbidity and mortality. Effective treatment of OSA with continuous positive airway pressure (CPAP) cou...
Autores principales: | Schlatzer, Christian, Bratton, Daniel J, Craig, Sonja E, Kohler, Malcolm, Stradling, John R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800120/ https://www.ncbi.nlm.nih.gov/pubmed/26983946 http://dx.doi.org/10.1136/bmjopen-2015-010150 |
Ejemplares similares
-
Effect of CPAP on blood pressure in patients with minimally symptomatic obstructive sleep apnoea: a meta-analysis using individual patient data from four randomised controlled trials
por: Bratton, Daniel J, et al.
Publicado: (2014) -
Effect of CPAP on cardiovascular events in minimally symptomatic OSA: long-term follow-up of the MOSAIC randomised controlled trial
por: Tang, Ivan, et al.
Publicado: (2020) -
Mechanisms of Atrial Fibrillation in Obstructive Sleep Apnoea
por: Saleeb-Mousa, James, et al.
Publicado: (2023) -
Stroke history higher in asymptomatic versus symptomatic atrial fibrillation patients
Publicado: (2018) -
ECG Predictors for New-Onset Atrial Fibrillation Within a Year After Radiofrequency Ablation of Counterclockwise-Rotating Atrial Flutter
por: Liu, Hailei, et al.
Publicado: (2021)